Lumito
0.534
SEK
+8.32 %
LUMITO
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
+8.32%
+6.37%
-32.32%
-46.33%
-66.58%
-62.92%
-28.99%
-89.55%
-59.69%
Lumito specializes in medical technology for digital pathology. The company strives to improve tissue diagnostics with its patented technology based on upconverted nanoparticles. The company plans to initially launch its first product for research laboratories. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito has its headquarters in Lund.
Read moreMarket cap
141.99M SEK
Turnover
560.35K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
20.2
2025
Annual report '24
8.5
2025
Interim report Q1'25
22.8
2025
Interim report Q2'25
ShowingAll content types
Lumito focus on the accelerated commercialisation of SCIZYS and are initiating a cost-reduction programme
Lumito refinances loan of SEK 12.5 million
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools